Publications by authors named "Jon Rowley"

Claim this Profile
S
Strategies for scalable manufacturing and translation of MSC-derived extracellular vesicles.
Katrina Adlerz, Divya Patel, Jon Rowley, Kelvin Ng, Tabassum Ahsan

Stem Cell Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel System.
Josephine Lembong, Robert Kirian, Joseph D Takacs, Timothy R Olsen, Lye Theng Lock, Jon A Rowley

Bioengineering (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioprocess decision support tool for scalable manufacture of extracellular vesicles.
Kelvin S Ng, James A Smith, Matthew P McAteer, Benjamin E Mead, Jamie Ware, Jon A Rowley

Biotechnol Bioeng· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corporate profile: RoosterBio, Inc.
Timothy R Olsen, Jon A Rowley

Regen Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peak MSC-Are We There Yet?
Timothy R Olsen, Kelvin S Ng, Lye T Lock, Tabassum Ahsan, Jon A Rowley

Front Med (Lausanne)· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggregation of Culture Expanded Human Mesenchymal Stem Cells in Microcarrier-based Bioreactor.
Xuegang Yuan, Ang-Chen Tsai, Iain Farrance, Jon Rowley, Teng Ma

Biochem Eng J· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concise Review: Process Development Considerations for Cell Therapy.
Andrew Campbell, Thomas Brieva, Lior Raviv, Jon Rowley, Knut Niss

Stem Cells Transl Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable passaging of adherent human pluripotent stem cells.
Ying Nie, Patrick Walsh, Diana L Clarke, Jon A Rowley, Thomas Fellner

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic cell therapy bioprocess economics and optimization: single-use cell expansion technologies.
Ana S Simaria, Sally Hassan, Hemanthram Varadaraju, Jon Rowley, Kim Warren

Biotechnol Bioeng· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potency assay development for cellular therapy products: an ISCT review of the requirements and experiences in the industry.
Christopher A Bravery, Jessica Carmen, Timothy Fong, Wanda Oprea, Karin H Hoogendoorn, Jon A Rowley

Cytotherapy· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing particulates in cellular therapy.
Dominic Clarke, Dorit Harati, Jerold Martin, Jon Rowley, Juergen Keller

Cytotherapy· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peak serum: implications of serum supply for cell therapy manufacturing.
David A Brindley, Natasha L Davie, Emily J Culme-Seymour, Chris Mason, David W Smith, Jon A Rowley

Regen Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing assays to address identity, potency, purity and safety: cell characterization in cell therapy process development.
Jessica Carmen, Scott R Burger, Michael McCaman, Jon A Rowley

Regen Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A changing time: the International Society for Cellular Therapy embraces its industry members.
Robert Deans, Kurt C Gunter, Timothy Allsopp, Mark Bonyhadi, Scott R Burger, Jon Rowley

Cytotherapy· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technologies for enhancing tissue engineering: materials and environments for guiding stem cell function. Preface.
Eben Alsberg, Jon A Rowley

Tissue Eng Part A· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrogels used for cell-based drug delivery.
John J Schmidt, Jon Rowley, Hyun Joon Kong

J Biomed Mater Res A· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method for determining oxygen consumption rates of static cultures from microplate measurements of pericellular dissolved oxygen concentration.
Richard D Guarino, Laura E Dike, Tariq A Haq, Jon A Rowley, J Bruce Pitner

Biotechnol Bioeng· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering growing tissues.
Eben Alsberg, Kenneth W Anderson, Amru Albeiruti, Jon A Rowley, David J Mooney

Proc Natl Acad Sci U S A· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alginate type and RGD density control myoblast phenotype.
Jon A Rowley, David J Mooney

J Biomed Mater Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis